POSSIBILITIES OF RENOPROTECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERURICEMIA.

Objective: The aim: To determine efficacy and safety of allopurinol and febuxostat in treatment of patients with CKD to reduce the sUA level and analyze its influence on glomerular filtration rate (GFR).

Patients And Methods: Materials and methods: The study included 45 CKD patients (stages 3b-5) without other severe/decompensated diseases and contraindications to the allopurinol/febuxostat. All patients underwent a comprehensive clinical and laboratory examination, and were divided into the study groups: Group I (28 patients, 61,3±3,2 y.

[Prognosis of pretreatment outcome in patients with acute glomerulonephritis after an immunological review].

Expediency has been shown for the immunological investigation to be done in those patients with acute glomerulonephritis in the nephrosis stage before the start of treatment to find out relevant approaches to such patients. The most informative parameters characterizing immunity include the peripheral blood absolute content T-lymphocytes, relative and absolute content of B-lymphocytes in the peripheral blood, IgA, IgG in blood plasma. However, to prognosticate near term clinical efficiency of treatment with immunodepressive drugs it is essential that all basic indices for the cell-bound and humoral immunity be taken account of.

[Lipid metabolic disorders in patients with glomerulonephritis in the presence of a herpetic infection].

Abnormalities were studied of lipid metabolism in patients with glomerulonephritis (GN) depending on the presence of herpes infection (antibodies to herpes simplex virus and cytomegalovirus) versus similar indices in GN patients free from this infection (n = 75). Of these, 34 presented with the urinary syndrome (US), 41 had nephrotic syndrome (NS). Abnormalities of lipid metabolism in GN patients (irrespective of the syndrome) were shown to be more manifest in the presence of herpes infection.